{
    "pmcid": "6640686",
    "qa_pairs": {
        "How can nanobodies be produced cost-effectively for therapeutic applications?": [
            "Nanobodies can be produced in microorganisms, allowing for cost-effective production.",
            "Nanobodies require mammalian cell cultures for production, increasing costs.",
            "Nanobodies are synthesized chemically, which is cost-prohibitive.",
            "Nanobodies are harvested from camelids, making production expensive."
        ],
        "How can nanobodies broaden their neutralizing activity against SARS-CoV-2 variants?": [
            "Combining nanobodies targeting different epitopes can broaden neutralizing activity.",
            "Using single nanobodies with high specificity reduces the risk of viral escape.",
            "Nanobodies are engineered to target only one epitope to enhance specificity.",
            "Nanobodies are modified to bind non-specifically to increase neutralization."
        ],
        "What is a key advantage of nanobodies over conventional antibodies in terms of size and structure?": [
            "Nanobodies are approximately 15 kDa, significantly smaller than conventional antibodies (~150 kDa).",
            "Nanobodies are approximately 150 kDa, similar in size to conventional antibodies.",
            "Nanobodies are approximately 50 kDa, slightly smaller than conventional antibodies.",
            "Nanobodies are approximately 100 kDa, making them larger than conventional antibodies."
        ],
        "What is a potential application of nanobodies in diagnostics?": [
            "Nanobodies have potential in rapid diagnostic tests due to their high specificity and stability.",
            "Nanobodies are primarily used in imaging techniques rather than diagnostics.",
            "Nanobodies are unsuitable for diagnostics due to their instability.",
            "Nanobodies are only used in therapeutic applications, not diagnostics."
        ],
        "What strategy is used to enhance the half-life of nanobodies in the body?": [
            "PEGylation, fusion to serum albumin, or Fc domains can extend the half-life of nanobodies.",
            "Nanobodies are encapsulated in liposomes to extend their half-life.",
            "Nanobodies are conjugated with gold nanoparticles to increase half-life.",
            "Nanobodies are linked to carbohydrates to prolong their half-life."
        ]
    }
}